Canadian homeopathic indications for use standards "insufficient" -- NDMAC.
This article was originally published in The Tan Sheet
CANADIAN HOMEOPATHIC INDICATION STANDARDS "INSUFFICIENT" to support efficacy of the products, the Nonprescription Drug Manufacturers Association of Canada asserts in April 2 comments on the Health Canada Drugs Directorate policy and guideline for indications for multi-ingredient low dilution homeopathic preparations. The policy became effective upon its March 24 release.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC